Stock Rich List
Nasdaq: ANIP

ANI Pharmaceuticals insiders

The officers, directors and 10% owners of ANI Pharmaceuticals, Inc. who hold the most stock, valued at the live ANIP price.

$69.13
ANIP today −$2.3M (−3.27%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
11
Their ANIP stock
$378M
Market value
$1.57B
Held by ranked insiders
24.1%

Insiders by value of ANIP holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Meridian Venture Partners II GP, L.P.10% owner2,019,259$140M8.88%Corporate
2Meridian Venture Partners II LP10% owner1,819,259$126M8.00%Corporate
3Muthusamy ShanmugamHEAD OF R&D, COO-NOVITIUM OPS537,976$37.2M2.37%3176th
4Nikhil LalwaniPRESIDENT & CEO328,289$22.7M1.44%4714th
5Chad GassertSVP - CORP. DEV. & STRATEGY233,406$16.1M1.03%6071st
6Stephen P. CareySVP & CFO166,143$11.5M0.73%7910th
7James G. MarkenSVP OPS & PROD DEV117,829$8.1M0.52%10253rd
8Christopher MutzHEAD OF RARE DISEASE91,309$6.3M0.40%12326th
9Ori GutwergSVP, GENERICS75,534$5.2M0.33%14038th
10Meredith W. CookSR. VP, GENERAL COUNSEL & SEC.72,924$5.0M0.32%14375th
11Henry O. GosebruchDirector6,662$461K<0.1%2475th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for ANI Pharmaceuticals; see each profile for the filing.